Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Colorcon
Dow
McKinsey
Johnson and Johnson

Last Updated: January 26, 2022

DrugPatentWatch Database Preview

Claims for Patent: 9,855,284

➤ Subscribe for complete access

« Back to Dashboard

Summary for Patent: 9,855,284
Title:Pharmaceutical compositions and methods
Abstract: This invention relates the use of cortisol blockers (e.g., glucocorticoid receptor [GR] antagonists) for the treating or preventing viral infections, treating or preventing treatment resistant prostate cancer, treating or preventing neoplasia, and treating or preventing infection related to acute or chronic injury or disease.
Inventor(s): Altschul; Randice Lisa (Cliffside Park, NJ), Theise; Neil David (New York, NY), Kesel; Andreas J. (Munich, DE), Rapkin; Myron (Indianapolis, IN), O\'Brien; Rebecca (Shell Knob, MO), Arment; Anthony R. (Fairborn, OH)
Assignee: Pop Test Oncology LLC (Cliffside Park, NJ)
Application Number:15/370,680
Patent Claims:1. A pharmaceutical composition comprising: a therapeutically effective amount of one or more of PT150, PT155, PT156, PT157, PT158, TCY1, combinations thereof and pharmaceutically acceptable salts thereof; at least one additional active agent selected from the group consisting of annexin-5, bavituximab, retinazone, RU486, Abacavir, Acyclovir, Adefovir, Amantadine, Amprenavir, rintatolimod, umifenovir, Atazanavir, Cidofovir, Dolutegravir, Delavirdine, Didanosine, Docosanol, Edoxudine, Efavirenz, Emtricitabine, Enfuvirtide, Entecavir, Famciclovir, Fomivirsen, Fosamprenavir, Foscarnet, Fosfonet, Ganciclovir, Ibacitabine, Inosine pranobex, Idoxuridine, Imiquimod, Indinavir, Inosine, Lamivudine, Lopinavir, Loviride, Maraviroc, Moroxydine, Methisazone, Nelfinavir, Nevirapine, Oseltamivir, Peginterferon alfa-2a, Penciclovir, Peramivir, Pleconaril, Podophyllotoxin, Raltegravir, Ribavirin, Rimantadine, Ritonavir, Pyramidine, Saquinavir, Sofosbuvir, Stavudine, Tea tree oil, Telaprevir, Tenofovir disoproxil, Tipranavir, Trifluridine, Tromantadine, Valaciclovir, Valganciclovir, Vicriviroc, Vidarabine, Viramidine, Zalcitabine, Zanamivir, Zidovudine, and combinations thereof; at least one pharmaceutically acceptable carrier, and optionally, and at least one blister package; a lidded blister, a blister card or packet; a clamshell; an intravenous (IV) package, IV packette or IV container, a tray or a shrink wrap comprising the pharmaceutical composition and instructions for use of the pharmaceutical composition.

2. A pharmaceutical composition comprising: at least one active agent selected from the group consisting of PT150, PT155, PT156, PT157, PT158, TCY1, combinations thereof; and pharmaceutically acceptable salts thereof; optionally, at least one additional active agent selected from the group consisting of oxycodone, hydrocodone, hydromorphone, and methadone.

3. The pharmaceutical composition of claim 2, wherein the composition is in a dosage form selected from the group consisting of a capsule, a tablet, a smart pill delivery device, a smart capsule delivery device, minicapsule, an implant, a troche, a lozenge (minitablet), a temporary or permanent suspension, an ovule, a suppository, a wafer, a chewable tablet, a quick or fast dissolving tablet, an effervescent tablet, a buccal or sublingual solid, a granule, a film, a sprinkle, a pellet, a bead, a pill, a powder, a triturate, a platelet, a strip or a sachet, nanoparticles, nanosuspension, and nanocapsules.

Details for Patent 9,855,284

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2002-10-16 ⤷  Sign up for a Free Trial 2035-08-03
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2004-01-07 ⤷  Sign up for a Free Trial 2035-08-03
Hoffmann-la Roche Inc. PEGASYS peginterferon alfa-2a Injection 103964 2011-09-29 ⤷  Sign up for a Free Trial 2035-08-03
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Harvard Business School
Express Scripts
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.